Sort
48,018 grants matching “immunotherapy”
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response
$485,903Shikhar Mehrotra · Medical University Of South Carolina · R01 · FY2024 · CA
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
$485,860Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2020 · CA
Clinical Trials in Mesothelioma
$485,852Daniel Sterman · University Of Pennsylvania · P01 · FY2008 · CA
The Role of Inflammation in Regulating Gastritis and Gastric Carcinogenesis
$485,826Richard J Dipaolo · Saint Louis University · R56 · FY2021 · DK
Acquisition of a Q-Exactive Plus Mass Spectrometer
$485,813William T Jewell · University Of California At Davis · S10 · FY2019 · OD
Modulation of Macrophage Polarization by Heterotrimeric G proteins: Implications of Gastrointestinal Inflammation
$485,810Pradipta Ghosh · University Of California, San Diego · R01 · FY2020 · AI
LHRH Synthetic Peptide Vaccine for Prostate Cancer
$485,806United Biomedical, Inc. · R44 · FY2003 · CA
PD-1 blockade with cryoablation and dendritic vaccine to treat lymphoma
$485,760Yi Lin · Mayo Clinic Rochester · R01 · FY2022 · CA
Evaluation of Immune-based Combinations in Prostate Cancer
$485,739Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Targeting cysteine import to induce ferroptotic cell death in pancreatic cancer
$485,683Kenneth P Olive · Columbia University Health Sciences · R01 · FY2024 · CA
TBD
$485,594Shuzhao Li · Jackson Laboratory · R01 · FY2020 · AI
Modulation of Macrophage Polarization by Heterotrimeric G proteins: Implications of Gastrointestinal Inflammation
$485,564Pradipta Ghosh · University Of California, San Diego · R01 · FY2019 · AI
EASTERN COOPERATIVE ONCOLOGY GROUP
$485,561Fox Chase Cancer Center · U10 · FY2002 · CA
Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer
$485,494Alex Jaeger · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer
$485,494Alex Jaeger · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
Ontogeny and Function of Tumor-Resident Innate Lymphocytes and Innate-Like T Cells
$485,492Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$485,465Edgar G. Engleman · Stanford University · R01 · FY2022 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$485,465Edgar G. Engleman · Stanford University · R01 · FY2023 · CA
Inflammation Phenotypes in Pediatric Sepsis Induced Multiple Organ Failure Renewal
$485,456Joseph A. Carcillo · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · GM
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
$485,407Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
$485,407Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Advancing immunotherapy through cross species studies of immune cell responses and immune checkpoint inhibitor effects in dogs and humans with invasive urinary bladder cancer
$485,357Deborah W Knapp · Purdue University · U01 · FY2024 · CA
Investigating the impact of chromosomal instability on prostate cancer aggressiveness
$485,354Veronica Rodriguez-Bravo · Mayo Clinic Rochester · R01 · FY2024 · CA
Investigating the impact of chromosomal instability on prostate cancer aggressiveness
$485,354Veronica Rodriguez-Bravo · Mayo Clinic Rochester · R01 · FY2025 · CA
Two Compartment Models to Improve Brain Tumor Therapy
$485,308Edward A Neuwelt · Oregon Health & Science University · R01 · FY2014 · CA